Quantum Genomics SA (ALQGC) - Cash Flow Conversion Efficiency

Latest as of June 2023: -4.706x

Based on the latest financial reports, Quantum Genomics SA (ALQGC) has a cash flow conversion efficiency ratio of -4.706x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-7.64 Million ≈ $-8.93 Million USD) by net assets (€1.62 Million ≈ $1.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Quantum Genomics SA for the company's overall valuation and market capitalisation.

Quantum Genomics SA - Cash Flow Conversion Efficiency Trend (2012–2022)

This chart illustrates how Quantum Genomics SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Quantum Genomics SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Quantum Genomics SA ranked by their cash flow conversion efficiency. See Quantum Genomics SA cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Bladeranger Ltd TA:BLRN	-0.058x
Locafy Ltd NASDAQ:LCFY	-0.083x
Novakand Pharma AB (publ) ST:LARK	0.006x
Princess Private Equity Holding Ltd LSE:PEYS	-0.002x
SIV Capital Ltd AU:SIV	0.020x
Harris Technology Group Ltd AU:HT8	0.187x
Thunderstruck Resources Ltd V:AWE	-0.004x
Nevada Sunrise Gold Corp V:NEV	-0.157x

Annual Cash Flow Conversion Efficiency for Quantum Genomics SA (2012–2022)

The table below shows the annual cash flow conversion efficiency of Quantum Genomics SA from 2012 to 2022. View today's stock price for Quantum Genomics SA for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	€3.61 Million ≈ $4.22 Million	€-20.21 Million ≈ $-23.63 Million	-5.603x	-218.28%
2021-12-31	€9.67 Million ≈ $11.30 Million	€-17.02 Million ≈ $-19.89 Million	-1.760x	-261.87%
2020-12-31	€24.65 Million ≈ $28.82 Million	€-11.99 Million ≈ $-14.02 Million	-0.486x	+56.12%
2019-12-31	€9.41 Million ≈ $11.00 Million	€-10.43 Million ≈ $-12.19 Million	-1.109x	-20.70%
2018-12-31	€11.87 Million ≈ $13.87 Million	€-10.90 Million ≈ $-12.74 Million	-0.919x	-2.15%
2017-12-31	€8.87 Million ≈ $10.37 Million	€-7.98 Million ≈ $-9.33 Million	-0.899x	-91.70%
2016-12-31	€11.79 Million ≈ $13.79 Million	€-5.53 Million ≈ $-6.47 Million	-0.469x	-19.75%
2015-12-31	€8.02 Million ≈ $9.38 Million	€-3.14 Million ≈ $-3.67 Million	-0.392x	-101.82%
2014-12-31	€-129.79K ≈ $-151.74K	€-2.79 Million ≈ $-3.26 Million	21.503x	+3447.81%
2013-12-31	€-1.63 Million ≈ $-1.90 Million	€-987.00K ≈ $-1.15 Million	0.606x	-9.37%
2012-12-31	€-918.08K ≈ $-1.07 Million	€-614.00K ≈ $-717.83K	0.669x	--

About Quantum Genomics SA

PA:ALQGC France Biotechnology

Market Cap

$5.87 Million

€5.02 Million EUR

Market Cap Rank

#28675 Global

#512 in France

Share Price

€0.07

Change (1 day)

+0.00%

52-Week Range

€0.07 - €0.07

All Time High

€9.73